Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.39 USD | -1.07% | -3.49% | -9.87% |
May. 10 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
May. 08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.87% | 1.43B | |
+39.18% | 723B | |
+34.28% | 595B | |
-4.27% | 369B | |
+20.15% | 332B | |
+2.61% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.09% | 168B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- HC Wainwright Lowers Price Target on Pacira BioSciences to $68 From $71, Maintains Buy Rating